Yubo International Biotech Limited
YBGJOTCHealthcare● Active
$0.01
+$0.00(+0.00%)
Market Cap$1006454
P/E Ratio—
52W High$0.1776
52W Low$0.0079
Yubo International Biotech Limited (YBGJ) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · YBGJ · as of 2026-06-15
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($1.08M) | ($1.78M) | ($1.20M) | ($1.54M) | ($0.71M) |
| Depreciation & Amort. | $0.18M | $0.18M | $0.03M | $0.02M | $0.01M |
| Stock-Based Comp. | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Change in Working Capital | $0.17M | $0.25M | $1.25M | $0.49M | $0.80M |
| Net Cash from Operations | ($0.84M) | ($1.34M) | $0.07M | ($1.02M) | $0.10M |
| Investing Activities | |||||
| Capital Expenditure | $0.00M | $0.00M | ($0.04M) | ($0.56M) | ($0.10M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | $0.00M | $0.12M | ($0.04M) | ($0.56M) | ($0.10M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | — | — | — |
| Net Cash from Financing | $0.85M | $1.41M | $0.00M | $0.13M | $1.38M |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.84M) | ($1.34M) | $0.03M | ($1.59M) | $0.00M |
| FCF Margin %(computed) | -627.13% | — | 27.29% | -127.42% | 0.27% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · USD · M
Explore more Yubo International Biotech Limited data
About Yubo International Biotech Limited (YBGJ) Cash Flow Statement
Yubo International Biotech Limited generated operating cash flow of ($0.00B) and free cash flow of ($0.00B) for 2025 — a FCF margin of -627.13%. Capital expenditure was $0.00B.
Frequently asked questions
YBGJ · 4 questionsYubo International Biotech Limited generated free cash flow of ($0.00B) for 2025, up 37.0% year-over-year.
YBGJ free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15